Armis Biopharma wins FDA approval for VeriFixx small bone implant

Armis Biopharma today said it received FDA approval for its VeriFixx Small Bone Implant.

The implant is designed for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe. VeriFixx can also make surgical corrections more accessible to patients in a shorter time to ambulation with a shorter overall recovery time and reduced pain, according to the company.